Soluble Flt‐1 as a diagnostic marker of pre‐eclampsia
Open Access
- 11 February 2008
- journal article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 48 (1), 64-70
- https://doi.org/10.1111/j.1479-828x.2007.00804.x
Abstract
Backgound: Serum levels of soluble fms-like tyrosine kinase (sFlt-1) increase in pre-eclampsia (PE). Aims: To determine whether concentrations of serum sFlt-1 can differentiate PE or superimposed PE (SPE) from gestational hypertension (GH) or chronic hypertension (CH). Methods: Blood was collected from pregnant women being investigated for hypertension (blood pressure of > 140 and/or 90 mmHg). Normotensive (NP) and pre-eclamptic (PE-C) control ranges were measured. Results: Patients with evolving hypertension in pregnancy eventually fell into four groups: GH (n = 14), PE (n = 7), CH (n = 9) and SPE (n = 9). Patients who later developed pre-eclampsia had a higher sFlt-1 (PE: 2.61 ng/mL and SPE: 2.77 ng/mL, respectively) than GH (P < 0.001) or CH (1.05 ng/mL, P = 0.11). Women with established PE at recruitment (PE-C; (n = 18) (3.13 ng/mL; interquartile range (IQR): 2.14–4.17 ng/mL) had a median sFlt-1 higher than NP (n = 18) (0.47 ng/mL; IQR: 0.11–0.89) (P < 0.0008). Patients with GH compared to NP had a slight increase (1.33 ng/mL, P < 0.003). Using a sFlt-1 cut-off of ≥ 1.9 ng/mL yielded a sensitivity of 94% (95% confidence interval (CI) 73–100%) and specificity of 78% (95% CI 64–82%). Conclusions: sFlt-1 was elevated in women with PE compared to NP. The sFlt-1 also differentiated women destined to develop PE among those who presented with a diagnostic rise in maternal blood pressure. The sFlt-1 test is a useful diagnostic test for PE.Keywords
This publication has 33 references indexed in Scilit:
- Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1Kidney International, 2007
- Preeclampsia in Lean Normotensive Normotolerant Pregnant Women Can Be Predicted by Simple Insulin Sensitivity IndexesHypertension, 2006
- Maternal Serum sFlt1 Concentration Is an Early and Reliable Predictive Marker of PreeclampsiaClinical Chemistry, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Recent Insights into the Pathogenesis of Pre-eclampsiaPlacenta, 2002
- Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin a as predictors of preeclampsia in the third trimester of pregnancyJournal of the Society for Gynecologic Investigation, 2000
- The detection, investigation and management of hypertension in pregnancy: executive summaryAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2000
- Perinatal morbidity and mortality in pregnancy hypertensive disorders: prognostic value of the clinical and laboratory findingsInternational Journal of Gynecology & Obstetrics, 1990
- Serum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancyJournal of Clinical Pathology, 1966